Your browser doesn't support javascript.
loading
Recent Advances in Radiotracers Targeting Novel Cancer-Specific Biomarkers in China: A Brief Overview.
Zhang, Jingming; Kang, Fei; Wang, Xiao; Chen, Xuejiao; Yang, Xing; Yang, Zhi; Wang, Jing.
Afiliación
  • Zhang J; Department of Nuclear Medicine, Peking University First Hospital, Beijing, China.
  • Kang F; Department of Nuclear Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
  • Wang X; State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Chen X; Department of Nuclear Medicine, Peking University First Hospital, Beijing, China.
  • Yang X; Department of Nuclear Medicine, Peking University First Hospital, Beijing, China.
  • Yang Z; Department of Nuclear Medicine, Peking University First Hospital, Beijing, China.
  • Wang J; Department of Central Laboratory, Peking University First Hospital, Beijing, China.
J Nucl Med ; 65(Suppl 1): 38S-45S, 2024 May 06.
Article en En | MEDLINE | ID: mdl-38719241
ABSTRACT
Radiopharmaceuticals play a critical role in nuclear medicine, providing novel tools for specifically delivering radioisotopes for the diagnosis and treatment of cancers. As the starting point for developing radiopharmaceuticals, cancer-specific biomarkers are important and receive worldwide attention. This field in China is currently experiencing a rapid expansion, with multiple radiotracers targeting novel targets being developed and translated into clinical studies. This review provides a brief overview of the exploration of novel imaging targets, preclinical evaluation of their targeting ligands, and translational research in China from 2020 to 2023, for detecting cancer, guiding targeted therapy, and visualizing the immune microenvironment. We believe that China will play an even more important role in the development of nuclear medicine in the world in the future.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trazadores Radiactivos / Biomarcadores de Tumor / Neoplasias Límite: Animals / Humans País/Región como asunto: Asia Idioma: En Revista: J Nucl Med Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trazadores Radiactivos / Biomarcadores de Tumor / Neoplasias Límite: Animals / Humans País/Región como asunto: Asia Idioma: En Revista: J Nucl Med Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos